Previous Article | Next Article ![]()
Infect. Immun., 11 1997, 4784-4789, Vol 65, No. 11
M Cinco, R Murgia, G Presani and S Perticarari
Like other pathogens, the spirochete Borrelia burgdorferi, the agent of
Lyme disease, possesses multiple pathways for cell binding; adhesion to
phagocytic cells is of particular interest since it reportedly occurs even
in the absence of specific antibodies. This study sets out to investigate
how B. burgdorferi binds to human polymorphonuclear leukocytes (PMNs) when
an exogenous complement is added and how the CR3 complement receptor, known
as Mac-1 or alpha(m)beta2 integrin, is involved in the binding process.
Experiments performed on PMNs and CHO Mac-1-expressing cells demonstrate
that binding is inhibited by monoclonal anti-iC3b site antibodies,
fibrinogen, and N-acetyl-D- glucosamine. These findings, which are not
present with non-Mac- transfected CHO cells, indicate that the integrin
alpha(m)beta2 acts as a receptor for spirochetes in nonimmune phagocytosis;
furthermore, binding occurs on different domains of the CD11b subunit,
involving the iC3b site and the lectin domain. The interaction of B.
burgdorferi with alpha(m)beta2 integrin adds a novel pathway to
Borrelia-phagocyte binding; not only does this binding affect the early
stages of phagocytosis, but also it can influence the effector
intracellular mechanisms which are activated by the beta2 integrin, as are
the cytotoxic mechanisms.
Copyright © 1997, American Society for Microbiology
Integrin CR3 mediates the binding of nonspecifically opsonized Borrelia burgdorferi to human phagocytes and mammalian cells
Dipartimento di Scienze Biomediche, Universita di Trieste, Italy. cinco@UNIV.trieste.it
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|